REPLIGEN CORP Goodwill, Foreign Currency Translation Gain (Loss)
REPLIGEN CORP (RGEN) reported Goodwill, Foreign Currency Translation Gain (Loss) of $9.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-07-29
- REPLIGEN CORP goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was $2.69M.
- REPLIGEN CORP goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was $6.82M.
- REPLIGEN CORP goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was -$1.55M, a 141.64% decline year-over-year.
- REPLIGEN CORP goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was $1.27M.
- REPLIGEN CORP goodwill, foreign currency translation gain (loss) for fiscal 2025 was -$33.40M, a 1152.24% decline from fiscal 2024.
- REPLIGEN CORP goodwill, foreign currency translation gain (loss) for fiscal 2024 was $3.17M.
- REPLIGEN CORP goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$1.51M, a 155.14% decline from fiscal 2022.
- REPLIGEN CORP goodwill, foreign currency translation gain (loss) for fiscal 2022 was $2.73M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $9.51M 10-Q · filed 2026-07-29 | $7.96M derived: sum of 3 quarters · filed 2026-07-29 | $9.23M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | $6.82M 10-Q · filed 2026-05-06 | $5.27M derived: sum of 2 quarters · filed 2026-05-06 | $6.54M derived: sum of 3 quarters · filed 2026-05-06 | -$25.29M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2025-12-31 | -$1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$279.00K derived: sum of 2 quarters · filed 2026-02-26 | -$32.11M derived: sum of 3 quarters · filed 2026-02-26 | -$33.40M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.27M derived: 10-K 12 month − 3 quarters · filed 2026-02-26 | -$30.56M derived: sum of 2 quarters · filed 2026-02-26 | -$31.84M 10-Q · filed 2025-11-04 | -$28.11M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | -$31.84M 10-Q · filed 2025-08-07 | -$33.12M derived: sum of 2 quarters · filed 2025-08-07 | -$29.39M derived: sum of 3 quarters · filed 2026-02-26 | -$31.40M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | -$1.28M 10-Q · filed 2025-08-07 | $2.45M derived: sum of 2 quarters · filed 2026-02-26 | $439.00K derived: sum of 3 quarters · filed 2026-02-26 | $789.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.72M derived: sum of 2 quarters · filed 2026-02-26 | $2.07M derived: sum of 3 quarters · filed 2026-02-26 | $3.17M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$1.66M derived: sum of 2 quarters · filed 2024-11-18 | -$556.00K 10-Q · filed 2024-11-18 | -$2.65M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2024-06-30 | $350.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $1.45M 10-Q/A · filed 2024-11-18 | -$639.00K derived: sum of 3 quarters · filed 2025-03-14 | $763.00K derived: sum of 4 quarters · filed 2025-03-14 | |
| 2024-03-31 | $1.10M 10-Q/A · filed 2024-11-18 | -$989.00K derived: sum of 2 quarters · filed 2025-03-14 | $413.00K derived: sum of 3 quarters · filed 2025-03-14 | $381.00K derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-12-31 | -$2.09M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | -$688.00K derived: sum of 2 quarters · filed 2025-03-14 | -$720.00K derived: sum of 3 quarters · filed 2025-03-14 | -$1.51M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $1.40M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $1.37M derived: sum of 2 quarters · filed 2024-11-18 | $582.00K 10-Q/A · filed 2024-11-18 | -$3.50M derived: sum of 4 quarters · filed 2024-11-18 | |
| 2023-06-30 | -$32.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$820.00K 10-Q/A · filed 2024-11-18 | -$4.90M derived: sum of 3 quarters · filed 2024-11-18 | -$1.96M derived: sum of 4 quarters · filed 2024-11-18 | |
| 2023-03-31 | -$788.00K 10-Q/A · filed 2024-11-18 | -$4.87M derived: sum of 2 quarters · filed 2024-11-18 | -$1.93M derived: sum of 3 quarters · filed 2024-11-18 | $1.07M derived: sum of 4 quarters · filed 2024-11-18 | |
| 2022-12-31 | -$4.08M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | -$1.14M derived: sum of 2 quarters · filed 2024-11-18 | $1.86M derived: sum of 3 quarters · filed 2024-11-18 | $2.73M 10-K/A · filed 2024-11-18 | -$2.73M 10-K · filed 2023-02-22 |
| 2022-09-30 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $5.93M derived: sum of 2 quarters · filed 2022-11-01 | $6.81M 10-Q · filed 2022-11-01 | $2.36M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2022-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $3.87M 10-Q · filed 2022-08-02 | -$574.00K derived: sum of 3 quarters · filed 2023-02-22 | $376.00K derived: sum of 4 quarters · filed 2023-02-22 | |
| 2022-03-31 | $878.00K 10-Q · filed 2022-04-27 | -$3.57M derived: sum of 2 quarters · filed 2023-02-22 | -$2.62M derived: sum of 3 quarters · filed 2023-02-22 | -$2.85M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-12-31 | -$4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$3.50M derived: sum of 2 quarters · filed 2023-02-22 | -$3.72M derived: sum of 3 quarters · filed 2023-02-22 | -$2.92M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $950.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $724.00K derived: sum of 2 quarters · filed 2021-10-28 | $1.53M 10-Q · filed 2021-10-28 | $723.00K derived: sum of 4 quarters · filed 2022-02-17 | |
| 2021-06-30 | -$226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $581.00K 10-Q · filed 2021-07-27 | -$227.00K derived: sum of 3 quarters · filed 2022-02-17 | -$972.00K derived: sum of 4 quarters · filed 2022-02-17 | |
| 2021-03-31 | $807.00K 10-Q · filed 2021-05-04 | -$1.00K derived: sum of 2 quarters · filed 2022-02-17 | -$746.00K derived: sum of 3 quarters · filed 2022-02-17 | -$1.09M derived: sum of 4 quarters · filed 2022-02-17 | |
| 2020-12-31 | -$808.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$1.55M derived: sum of 2 quarters · filed 2022-02-17 | -$1.90M derived: sum of 3 quarters · filed 2022-02-17 | -$1.57M 10-K · filed 2022-02-17 | |
| 2020-09-30 | -$745.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$1.09M derived: sum of 2 quarters · filed 2020-11-05 | -$764.00K 10-Q · filed 2020-11-05 | -$1.21M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2020-06-30 | -$343.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$19.00K 10-Q · filed 2020-07-30 | -$469.00K derived: sum of 3 quarters · filed 2021-02-24 | $218.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2020-03-31 | $324.00K 10-Q · filed 2020-05-06 | -$126.00K derived: sum of 2 quarters · filed 2021-02-24 | $561.00K derived: sum of 3 quarters · filed 2021-02-24 | $327.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-12-31 | -$450.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $237.00K derived: sum of 2 quarters · filed 2021-02-24 | $3.00K derived: sum of 3 quarters · filed 2021-02-24 | $343.00K 10-K · filed 2021-02-24 | |
| 2019-09-30 | $687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $453.00K derived: sum of 2 quarters · filed 2019-10-31 | $793.00K 10-Q · filed 2019-10-31 | ||
| 2019-06-30 | -$234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $106.00K 10-Q · filed 2019-08-01 | |||
| 2019-03-31 | $340.00K 10-Q · filed 2019-05-09 | ||||
| 2018-12-31 | $801.00K 10-K · filed 2020-02-26 | ||||
| 2017-12-31 | -$2.18M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |